Skip to content

Clinical efficacy of Cangfu ovulatory decoction on overweight infertility: a randomized controlled study

Clinical efficacy of Cangfu ovulatory decoction on overweight infertility: a randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057186
Enrollment
Unknown
Registered
2022-03-02
Start date
2022-02-18
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Control group:None
Experimental group:Oral Cangfu Ovulation Decoction

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing IVF due to tubal factors or ovulation disorders. 2. The semen results of the male husband were normal. 3. In line with the dialectical standard of TCM phlegm and blood stasis syndrome type. 4. Aged 20-35 years. 5. BMI 24-28 kg/m ^ 2. 6. No ovulation stimulating drugs were taken within 3 months. 7. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with endometriosis, organic lesions of the uterus or endometrium, thyroid disease, or other endocrine disorders. 2. Allergic to traditional Chinese medicine or western medicine.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;Number of high-quality embryos/rate;

Secondary

MeasureTime frame
Ovarian responsiveness index;Early miscarriage rate;TCM syndrome score;

Countries

China

Contacts

Public ContactLiu Dan

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Dahlia929@163.com+86 19821267618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026